SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-24-060155
Filing Date
2024-07-09
Accepted
2024-07-09 17:01:37
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 ea0209043-s3a1_biomx.htm S-3/A 502682
2 OPINION OF HAYNES AND BOONE, LLP ea020904301ex5-1_biomx.htm EX-5.1 19618
3 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea020904301ex23-1_biomx.htm EX-23.1 2126
4 GRAPHIC image_001.jpg GRAPHIC 4376
5 GRAPHIC ex5-1_001.jpg GRAPHIC 2865
6 GRAPHIC ex5-1_002.jpg GRAPHIC 1329
  Complete submission text file 0001213900-24-060155.txt   537778
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-278986 | Film No.: 241108001
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)